Wed.Dec 27, 2023

article thumbnail

Quitting alcohol — or even drinking less — reduces risk of oral cavity and esophageal cancer, per new analysis

STAT

Reducing or eliminating alcohol consumption reduces the risk of developing oral cavity and esophagus cancers, according to a special report from the International Agency for Research on Cancer. But more data are needed to conclude whether the same is true for several other cancer types, including colorectal, breast, and liver cancer. Even so, it is likely that reducing or ceasing to drink alcohol will lessen the risk of these cancers, said Farhad Islami, a cancer epidemiologist at the American C

363
363
article thumbnail

Insulin Storage and Beyond Use Dates – Free Downloadable PDF

Med Ed 101

We’ve taken the time to create a new free PDF resource. In my practice, I always run into nursing staff and caregivers who are using expired insulin or who are not dating the insulins that are in use. Insulin Storage and Beyond Use Dates Free PDF should be a vital resource designed to help healthcare […] The post Insulin Storage and Beyond Use Dates – Free Downloadable PDF appeared first on Med Ed 101.

Diabetes 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: Remembering Betty Rollin, who told her breast surgeon that post-operative appearance mattered to her—and other women

STAT

Women who had undergone disfiguring surgery for breast cancer, according to one surgeon in the 1970s, needed to “stick an old sock in their bra and get on with their lives.” It was this climate that Betty Rollin, then a television correspondent for NBC, entered when she was diagnosed with the disease in 1975. Rollin, who died of voluntary assisted suicide in Switzerland in November at age 87, became a highly visible activist not only for women with breast cancer but also end-of-lif

341
341
article thumbnail

Akums launches Doxylamine + Pyridoxine ER tablets

Express Pharma

Akums Drugs and Pharmaceuticals announced the launch of Doxylamine + Pyridoxine extended-release tablets, a therapy approved by the CSDCO, India and the USFDA. Doxylamine, a competitive histamine H1 receptor inhibitor with sedative and anticholinergic effects, is paired with Pyridoxine Hydrochloride (Vitamin B6), known for its anti-emetic properties and its role in haemoglobin production and neurotransmitter metabolism.

94
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Cytokinetics heart drug aficamten succeeds in pivotal study

STAT

An experimental medicine from Cytokinetics significantly improved exercise capacity for patients with a rare, progressive heart disease, the company said Wednesday — a result that compared favorably with a competing treatment from Bristol Myers Squibb. The study enrolled about 300 people with obstructive hypertrophic cardiomyopathy, or HCM, a hereditary disorder that restricts blood flow.

305
305
article thumbnail

Menarini India signs pact with Pierre Fabre Laboratories

Express Pharma

A. Menarini India has signed an exclusive partnership with esteemed French pharma company – Pierre Fabre Laboratories. Under this strategic collaboration, Menarini India has obtained exclusive rights to market and distribute the dermo-cosmetic brands, EAU THERMALE AVÈNE and DUCRAY in India. EAU THERMALE A VÈNE, a Pierre Fabre dermo-cosmetic brand, is for sensitive, intolerant, and allergic skin with solutions cleansing, moisturising, sun care, anti-aging, anti-acne, and hyperpigmentation.

94

More Trending

article thumbnail

AstraZeneca buys Chinese CAR-T biotech Gracell in a $1.2bn deal

Pharmaceutical Technology

The deal is worth approximately $1.2bn in combined upfront and potential contingent value payments and is expected to close in Q1 2024.

98
article thumbnail

STAT+: What comes after Wegovy? The quest to eradicate obesity

STAT

About a decade ago, after becoming obese, Jacob Petersen lost weight so quickly that some colleagues worried he might have cancer. Petersen, who was then the head of global metabolic research at Novo Nordisk, hadn’t turned to his company’s famed medicines like Ozempic and Wegovy — the wildly effective drugs didn’t exist yet.

article thumbnail

Ultragenyx Picks Andelyn Biosciences to Manufacture Novel Gene Therapy for Sanfilippo Syndrome

PharmaTech

Andelyn Biosciences has been selected by Ultragenyx to manufacture UX111, that company’s gene therapy for treating Sanfilippo Syndrome.

97
article thumbnail

Violet CEO on measuring clinician inclusiveness: ‘It’s almost like a credit score’

STAT

PHOENIX, Ariz. — Gaurang Choksi is the founder and CEO of Violet , a health equity platform that aims to standardize and increase cultural competence among clinicians. The New York-based startup provides inclusivity training for clinicians in order to help promote identity-centered health care, particularly for patients who typically face greater barriers to receiving quality care because of their race, ethnic or gender identity.

223
223
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Lupin gets US FDA approval for Loteprednol Etabonate Ophthalmic Suspension, 0.2%

Express Pharma

Lupin has received approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Loteprednol Etabonate Ophthalmic Suspension, 0.2%, to market a generic equivalent to the reference listed drug (RLD) Alrex Ophthalmic Suspension, 0.2%, of Bausch & Lomb. The product will be manufactured at Lupin’s Pithampur facility in India.

82
article thumbnail

STAT+: 3 issues to watch in pharma in 2024

STAT

As another year comes to an end and the world seems to hit the proverbial pause button, the temptation to look ahead is too great to ignore. After all, this is what journalists like to do as the calendar turns another page. So once again, we will take a whack at identifying some of the most noteworthy developments to watch. However, if these seem familiar, there is good reason.

article thumbnail

BMS strikes again, with $4.1bn RayzeBio takeover bid

pharmaphorum

Bristol-Myers Squibb makes a foray into the radiopharmaceutical category with a $4.

111
111
article thumbnail

STAT+: 3 FDA staffers to watch in 2024

STAT

WASHINGTON — The Food and Drug Administration has a lot on its plate in 2024 with the reorganizations of its food center and the office that inspects FDA-regulated facilities. Amid that massive reorganization, the FDA also will lose one of its most influential leaders. Janet Woodcock is retiring at the beginning of the year after decades of service.

207
207
article thumbnail

Drivers of global health impact in 2024

Quality Matters

Drivers of global health impact in 2024 Reflecting on 2023 to inform change in the New Year Hindsight is a gift, as the saying goes, and as we close out the year, it is easy to see that 2023 was pivotal for global health. Notably, the public health emergency due to COVID-19 ended, even as new variants emerged and efforts to address the lasting impacts of the pandemic continued.

article thumbnail

Looking to the future of UK medical device exports

pharmaphorum

In this second of our festive podcast series, the pharmaphorum podcast welcomed Brandon Medical CEO Keith Jackson and the Association of British HealthTech Industries (or ABHI) director of communications, Jonathan Evans, to discuss UK medical device exports, including a particular recent strategic APAC partnership and the general and ongoing representation of industry innovation to stakeholders including government, NHS, and regulators.

article thumbnail

New patent for IMPAX drug TWINJECT 0.15

Drug Patent Watch

Annual Drug Patent Expirations for TWINJECT+0.15 Twinject 0.15 is a drug marketed by Impax and is included in one NDA. It is available from four suppliers. There are two patents… The post New patent for IMPAX drug TWINJECT 0.15 appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

The rapidly evolving role of patient organisations

pharmaphorum

Patient organisations play a crucial role in the rapidly evolving landscape of healthcare, life sciences, and research. Learn about their role in advocacy, research, and navigating regulatory processes in this informative article.

62
article thumbnail

New patent for IMPAX drug TWINJECT 0.3

Drug Patent Watch

Annual Drug Patent Expirations for TWINJECT+0.3 Twinject 0.3 is a drug marketed by Impax and is included in one NDA. It is available from four suppliers. There are two patents… The post New patent for IMPAX drug TWINJECT 0.3 appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Innovent and SanegeneBio partner for hypertension drug development

Pharmaceutical Business Review

Designed based on the Ligand and Enhancer Assisted Delivery (LEAD) platform of SanegeneBio, SGB-3908 is currently in the investigational new drug application (IND)-enabling stage of development. Both Innovent and SanegeneBio will jointly advance the SGB-3908 development until a specific stage. Subsequently, Innovent will have the sole licencing rights for the further development, production, and marketing of the drug across the globe and will make option exercise fee payments to SanegeneBio.

article thumbnail

New patent for IMPAX drug ADRENACLICK

Drug Patent Watch

Annual Drug Patent Expirations for ADRENACLICK Adrenaclick is a drug marketed by Impax and is included in one NDA. It is available from four suppliers. There are two patents protecting… The post New patent for IMPAX drug ADRENACLICK appeared first on DrugPatentWatch - Make Better Decisions.

59
article thumbnail

Update: Apple Watches back on sale after appeal

pharmaphorum

Apple will appeal a decision by the USTR not to veto a ban on US imports of some of its smartwatches, found to violate patents held by wearables company Masimo

62
article thumbnail

Top Marketing Stories of 2023

PharmExec

Pharma marketing teams had to deal with big changes in 2023.

98
article thumbnail

Organic chemistry research transformed: The convergence of automation and AI reshapes scientific exploration

World Pharma News

Recently, National Science Open magazine published online a review article led by Professor Fanyang Mo (School of Materials Science and Engineering, Peking University) and Professor Yuntian Chen (Eastern Institute of Technology, Ningbo). The research team proposed a significant shift towards automation and artificial intelligence (AI) in organic chemistry over the past decade.

58
article thumbnail

Essential Nutrients Your Body Needs: Omega-3 Benefits

Welltopia Pharmacy

Essential Nutrients Your Body Needs: Unlock the benefits of Omega-3s for heart, brain, and overall health with WellPure Omega 1300 EC.

67
article thumbnail

European Medicines Regulatory Network on Track to Meet Goals

PharmaTech

The midterm report of the European Medicines Agencies Network Strategy finds that the network has strengthened and is on track to achieve its objectives.

52
article thumbnail

Bristol Myers Squibb agrees to acquire RPT company RayzeBio for $4.1bn

Pharmaceutical Technology

Bristol Myers Squibb (BMS) has signed a definitive agreement for the acquisition of RayzeBio in a total equity value of nearly $4.1bn.

52
article thumbnail

Top 3 Most-Read Supply Chain Logistics Pieces of the Year

Pharmaceutical Commerce

The most popular pieces pertaining to the supply chain featured ADMs, vaccine supply chains, and wholesalers.

article thumbnail

ARTBIO divulges plans for proprietary isotope manufacturing technology

Pharmaceutical Technology

ARTBIO is developing a proprietary radiotherapy manufacturing technology to overcome distribution and supply chain challenges.

52
article thumbnail

Our Top 5 Podcast Episodes of 2023

PharmExec

Our top five episodes of the year.

52
article thumbnail

Eligibility Factors in Multiple Myeloma Transplant

Pharmacy Times

Gabriel Hinojosa, PharmD, BCOP, analyzes eligibility factors and treatment shifts in multiple myeloma care, considering autologous stem cell transplant risks and evolving therapy approaches with daratumumab.

26
article thumbnail

Opinion: People with food insecurity deserve better nutrition education

STAT

Since spring 2022, a flood of migrants fleeing political instability in Venezuela — about 136,000 — have settled in Queens, New York, and are in desperate need of food and other resources. The surging migrant population has led to depleted food pantries in the borough; as of June 2023, more than 20.5% of Queens residents are experiencing food insecurity.

257
257
article thumbnail

Top 5 Pharmacy Times Reimbursement Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read reimbursement-related articles on Pharmacy Times in 2023.

26
article thumbnail

Which pharmaceutical companies have the most drug patents in Czech Republic?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Czech Republic. Patents must be filed in each country (or, in some cases regional patent office) where patent protection… The post Which pharmaceutical companies have the most drug patents in Czech Republic? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Top 5 Pharmacy Times Pneumococcal Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read pneumococcal-related articles on Pharmacy Times in 2023.

26